PROFECTUS BIOSCIENCES
Profectus Biosciences is a research and development company dedicated to harnessing the immune system to treat and prevent viral diseases and cancers through the delivery of our proprietary prime/boost vaccines and small molecules.
PROFECTUS BIOSCIENCES
Social Links:
Industry:
Biotechnology Electronic Health Record (EHR) Health Care Health Diagnostics
Founded:
2002-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.profectusbiosciences.com
Total Employee:
11+
Status:
Active
Contact:
4106335709
Email Addresses:
[email protected]
Total Funding:
34.67 M USD
Technology used in webpage:
Domain Not Resolving SPF Google Maps Microsoft Exchange Online Office 365 Mail GStatic Google Static Content Google Maps API Unified Layer HostMonster DNS
Similar Organizations
Idenix Pharmaceuticals
Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
Cross Atlantic Capital Partners
Cross Atlantic Capital Partners investment in Venture Round - Profectus Biosciences
Cross Atlantic Capital Partners
Cross Atlantic Capital Partners investment in Venture Round - Profectus Biosciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-04-09 | The University of Texas Medical Branch | Profectus Biosciences investment in Grant - The University of Texas Medical Branch | 35 M USD |
Official Site Inspections
http://www.profectusbiosciences.com
- Host name: 74-220-203-200.unifiedlayer.com
- IP address: 74.220.203.200
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Profectus Biosciences"
Profectus BioSciences, Inc - LinkedIn
Profectus BioSciences, Inc | 573 followers on LinkedIn. Profectus BioSciences is an innovative clinical stage vaccine company devoted to preventing and treating viral diseases and malaria through ...See details»
Profectus Biosciences, Inc. Company Profile | Pearl River, NY ...
Find company research, competitor information, contact details & financial data for Profectus Biosciences, Inc. of Pearl River, NY. Get the latest business insights from Dun & Bradstreet.See details»
Profectus Biosciences Inc - Company Profile and News
Profectus Biosciences, Inc. develops vaccines. The Company offers vaccine products to address diseases caused by hepatitis C, human immunodeficiency, human papilloma, and herpes …See details»
Profectus Biosciences (PBS) - Devex
Learn more about Profectus Biosciences (PBS)'s jobs, projects, latest news, contact information and geographical presence. ... Type of organization. Development Consulting Service …See details»
Profectus BioSciences - PitchBook
Profectus BioSciences General Information Description. Developer of preventive, therapeutic, and oncolytic vaccines designed to treat and prevent viral diseases. The company's vaccines are used for infectious diseases and cancer …See details»
Profectus BioSciences - Craft
Profectus BioSciences is a company that provides vaccines for infectious diseases and cancer immunotherapy. It uses a proprietary technology platform for the development of vaccines …See details»
Aurobindo Pharma Acquires Certain Assets of Profectus …
Aurobindo Pharma USA, Inc., finalized the asset acquisition transaction with Profectus BioSciences Inc. This new subsidiary is called Auro Vaccines LLC. Profectus BioSciences Inc. …See details»
CEPI Awards Contract Worth up to $36 million to Profectus …
CEPI (the Coalition for Epidemic Preparedness Innovations) today announced a new collaboration with Profectus BioSciences, Inc. and Emergent BioSolutions Inc. (NYSE: EBS) under which …See details»
Profectus Biosciences - Contacts, Employees, Board Members
Profectus Biosciences is a R&D company developing vaccine and small molecules to treat and prevent viral diseases and cancers. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
CEPI Awards $25 Million Contract to Profectus …
OSLO, Norway, BALTIMORE and GAITHERSBURG, Md., May 24, 2018. CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus BioSciences, Inc. and Emergent BioSolutions Inc. …See details»
The BioBuzz on . . . Profectus BioSciences, Inc.’s President Jeffrey N ...
Leader: Jeffrey “Jeff” Meshulam, President, Profectus BioSciences, Inc. Location: Baltimore, MD/Tarrytown, NY Overview: Profectus is a clinical-stage biotechnology company pioneering …See details»
CEPI Awards $25 Million Contract to Profectus BioSciences and …
The international nonprofit organization PATH will also be working with the consortium under a separate agreement with CEPI to work on clinical development. Nipah virus and Hendra virus …See details»
Emergent and Profectus receive CEPI contract for Lassa virus vaccine
The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway has awarded a contract to US-based Emergent BioSolutions and Profectus BioSciences to develop and manufacture a …See details»
Profectus, Emergent BioSolutions nab CEPI’s $36M contract for …
Aug 20, 2018 Shortly after winning $25 million in funding for work on a Nipah virus vaccine, Profectus BioSciences and Emergent BioSolutions have nabbed a new contract worth up to …See details»
CEPI Awards $25 Million Contract to Profectus BioSciences and …
CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus BioSciences, Inc. and Emergent BioSolutions Inc. (NYSE:EBS) under which …See details»
Profectus and Vyriad Form Global Collaboration to Develop …
Mar 18, 2016 Profectus BioSciences is a clinical-stage vaccine development company developing preventive and therapeutic vaccines for infectious diseases and oncolytic vaccines …See details»
Profectus, Emergent BioSolutions and PATH join forces in search …
May 25, 2018 The global alliance plans to grant up to $25 million over the next five years to Profectus BioSciences and Emergent BioSolutions, which are working on a candidate to …See details»